53901-68-1Relevant academic research and scientific papers
Aralkanamidophenyl compounds
-
, (2008/06/13)
This disclosure describes novel substituted aralkanamidobenzoic acids and analogs thereof. These compounds are useful pharmaceutical agents for ameliorating atherosclerosis by inhibiting the formation and development of atherosclerotic lesions in the arterial wall of mammals.
Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogues of cetaben
Albright,DeVries,Largis,Miner,Reich,Schaffer,Shepherd,Upeslacis
, p. 1378 - 1393 (2007/10/02)
The syntheses of a series of (aralkylamino)- and (alkylamino)benzoic acids, as well as the corresponding esters and sodium salts, are described. The compounds were evaluated in vivo in rats for serum sterol and triglyceride lowering activity and in vitro
